Dow futures soar 1,500 points after Pfizer, BioNTech say coronavirus vaccine candidate 90% effective

U.S. stock-index futures on Monday were soaring after Germany-based BioNTech SE and Pfizer Inc. said their COVID-19 vaccine candidate achieved "success" in the first interim analysis of from a Phase 3 study.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.